Bellicum To Participate In Fireside Chat At The Piper Jaffray 27th Annual Healthcare Conference

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that Tom Farrell, President and CEO, will participate in an analyst-led fireside chat at the 27th Annual Piper Jaffray Healthcare Conference. The fireside chat will take place on Wednesday, December 2, 2015 at 12:30 p.m. EST at The New York Palace Hotel.

Back to news